Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.
Science
; 353(6295): 179-84, 2016 Jul 08.
Article
in En
| MEDLINE
| ID: mdl-27365313
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoantibodies
/
Recombinant Fusion Proteins
/
Receptors, Antigen, T-Cell
/
T-Lymphocytes
/
Immunosuppression Therapy
/
Pemphigus
/
Desmoglein 3
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Science
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
United States